Austria | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Austria totalled $ 17.5 billion in 2023. Sales of commodity group 30 from Austria went up by 27% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 3.81 billion (cumulative exports of commodity group 30 from Austria amounted $13.7 billion in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 8.13% of total exports from Austria (cumulative merchandise exports from Austria totalled $ 216 billion in 2023). The share of commodity group 30 in total exports from Austria increased by 1.58 p.p. compared to 2022 (it was 6.54% in 2022 and cumulative exports from Austria were equal to $ 210 billion).
Where does Austria export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Austria in 2023:
- Germany with a share of 19.3% (3.4 billion US$)
- USA with a share of 15.2% (2.68 billion US$)
- Switzerland with a share of 12.6% (2.23 billion US$)
- Poland with a share of 8.66% (1.52 billion US$)
- Belgium with a share of 4.72% (830 million US$)
- Italy with a share of 3.74% (659 million US$)
- Russia with a share of 3.42% (602 million US$)
- France with a share of 2.63% (463 million US$)
- China with a share of 2.34% (412 million US$)
- Czech Republic with a share of 2.19% (386 million US$)
Exports structure of 30 - Pharmaceutical products - from Austria in 2023 represented by the following main commodity groups:
- 57% (10.1 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 38% (6.81 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 2.21% (389 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.684% (120 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.501% (88 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 0.108% (19 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
The value of imports of commodity group 30 "Pharmaceutical products" to Austria totalled $ 11.2 billion in 2023. Sales of commodity group 30 to Austria went up by 11.3% compared to 2022: imports of commodity group 30 "Pharmaceutical products" went up by $ 1.15 billion (the value of imports of commodity group 30 to Austria was equal to $10.1 billion in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 5.14% of total import flow to Austria (in 2023, total imports to Austria amounted to $ 219 billion). The share of commodity group 30 in total imports to Austria increased by 0.781 p.p. compared to 2022 (it was 4.36% in 2022 and cumulative imports to Austria were equal to $ 231 billion).
Where does Austria import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Austria in 2023:
- Germany with a share of 24% (2.72 billion US$)
- USA with a share of 23% (2.69 billion US$)
- Italy with a share of 7.68% (867 million US$)
- Switzerland with a share of 7.54% (850 million US$)
- France with a share of 5.17% (583 million US$)
- Netherlands with a share of 5.15% (581 million US$)
- Sweden with a share of 4.24% (478 million US$)
- Ireland with a share of 2.68% (303 million US$)
- Czech Republic with a share of 2.14% (242 million US$)
- United Kingdom with a share of 1.87% (211 million US$)
Imports structure of 30 - Pharmaceutical products - to Austria in 2023 represented by the following main commodity groups:
- 54% (6.12 billion US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 39% (4.44 billion US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 1.88% (212 million US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 1.41% (159 million US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.17% (131 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.261% (29 million US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
